| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CNCY.20016 |
| P698 | PubMed publication ID | 19347824 |
| P2093 | author name string | Guido Dalbagni | |
| Oscar Lin | |||
| Harry Herr | |||
| Suresh Jhanwar | |||
| Ryan Denley | |||
| Susana Ferra | |||
| P2860 | cites work | Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer | Q34978029 |
| Bladder cancer: epidemiology, diagnosis, and management | Q34983298 | ||
| Urothelial cancer biomarkers for detection and surveillance | Q36418389 | ||
| The clinical value of urinary cytology: 12 years of experience with 615 patients | Q37260189 | ||
| Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. | Q40620941 | ||
| Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience | Q40860531 | ||
| The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine | Q42721217 | ||
| Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer | Q47370098 | ||
| Deletion of the p16 and p15 Genes in Human Bladder Tumors | Q57562859 | ||
| Intratumoral heterogeneity in DNA ploidy of bladder carcinomas | Q68006228 | ||
| Origins and clinical implications of aneuploidy in early bladder cancer | Q71374132 | ||
| A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma | Q73062815 | ||
| DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH | Q73174810 | ||
| Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma | Q73439871 | ||
| Improved detection of recurrent bladder cancer using the Bard BTA stat Test | Q73707842 | ||
| Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings | Q74182268 | ||
| Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer | Q77214844 | ||
| Comparison of screening methods in the detection of bladder cancer | Q77895609 | ||
| UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer | Q79329213 | ||
| Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings | Q79517685 | ||
| P433 | issue | 1 | |
| P921 | main subject | cell biology | Q7141 |
| P304 | page(s) | 7-14 | |
| P577 | publication date | 2009-02-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Reflex UroVysion testing in suspicious urine cytology cases | |
| P478 | volume | 117 |
| Q84475759 | A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: A prospective study |
| Q37781786 | A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis |
| Q34016615 | Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis. |
| Q35075808 | Comparative study of ProEx C immunocytochemistry and UroVysion fluorescent in-situ hybridization assays on urine cytology specimens |
| Q64954033 | Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results. |
| Q27021371 | Emerging critical role of molecular testing in diagnostic genitourinary pathology |
| Q41839758 | Evaluation of a triple combination of cytokeratin 20, p53 and CD44 for improving detection of urothelial carcinoma in urine cytology specimens |
| Q37238810 | Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation |
| Q46304737 | Exclusion of the uniform tetraploid cells significantly improves specificity of the urine FISH assay |
| Q37967115 | Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? |
| Q39693001 | One-year monitoring of an oligonucleotide fluorescence in situ hybridization probe panel laboratory-developed test for bladder cancer detection |
| Q33686437 | Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma |
| Q37705271 | Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy |
| Q37745519 | Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology |
| Q84615556 | UroVysion, Urine Cytology, and the College of American Pathologists: Where Should We Go From Here? |
| Q39763864 | Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria |
| Q33555932 | Utility of molecular tests in cytopathology |
Search more.